Neurology Virtual 2020: 3rd Edition

After the successful completion of two Editions, INBC is pleased to announce its 3rd Edition of "NEUROLOGY VIRTUAL 2020" during November 19-20, 2020. 3rd International Webinar on Neurology and Brain Disorders will offer you an impressive roaster of speakers, quality attendees and compelling content and is an excellent opportunity for leading academicians and scholars from universities and institutes to...

Diversity and Inclusion in the Life Science Industry

Biocom's Device & Diagnostics Committee Presents: Diversity and Inclusion in the Life Science Industry Join us for an open discussion on what some of the key challenges are and what we can do as a community to move the needle on an issue that is critical for our industry to grow and develop. How do...

LSPA Clinical Trial Virtual Summit

The 2020 Clinical Trial Summit is a half-day program designed specifically for those planning and conducting clinical trials or those who are seeking advice when selecting outsourced providers.

iGEM Startup Showcase 2020

The Entrepreneurship Program Innovation Community (EPIC) supports the development of iGEMs entrepreneurial community. The vision of the program is to become the driving force behind hundreds of SynBio based start-ups globally to help accelerate our transition to a more sustainable bioeconomy. The core of the program is focused on supporting iGEMers by connecting them to relevant co-founders,...

A Conversation with Jennifer Doudna, 2020 Nobel Laureate

CRISPR pioneer Jennifer Doudna, PhD (University of California, Berkeley/HHMI) was recently awarded the 2020 Nobel Prize in Chemistry with Emmanuelle Charpentier, PhD, a microbiologist at the Max Planck Institute in Berlin. In 2012, the Doudna and Charpentier labs teamed up to publish a landmark paper in which they adapted the CRISPR microbial anti-viral defense system...

Halloran Town Hall: Chasing Your Data…and Winning the Race!

As an industry, we produce data. Lots of it. It is inherent to what we do and clearly necessary for bringing innovative therapies to patients. Whether it is monitoring patient data for safety or operational data for oversight purposes, the pandemic has escalated data accessibility to a top strategic priority for companies. Increasingly, Sponsors are...

mRNA Day 2020: Celebrating the Past, Present, and Future of mRNA

In celebration of mRNA Day 2020, TriLink is proud to present back-to-back webinars by two pioneers of the mRNA therapeutic platform: Dr. Katalin Kariko and Dr. Drew Weissman. Dr. Kariko will provide an overview of the history of mRNA therapeutics, while Dr. Weissman will provide his perspective on the future of mRNA medicines. In a...

Biotechgate Digital Partnering

Join four days of digital partnering and establish new global connections thanks to pre-arranged one-on-one ZOOM meetings. Biotechgate Digital Partnering is designed to support the business development of Biotech, Medtech and Pharma companies.

MassBio Town Hall – 2021 Biotech Outlook

MassBio’s President & CEO, Bob Coughlin, will host a regular virtual Town Hall for members. This will be an opportunity for our members to ask questions, hear what MassBio is up to, and learn more about the state of the industry amidst the COVID-19 pandemic. This Town Hall will feature Matthew Harrison, a Managing Director and...

Webinar: 2021 Preview: A 360 Degree Global Market View

Join BIO and LaVoieHealthScience for our next Global Market View webinar on December 1 at 10:30AM ET. Our panel of industry leaders with share their perspectives on several topics including private, public, US, EU and China markets, JPM virtual week, the 2020 election, new company formation, year-end regulatory reviews and record financing through NewCo IPO's,...

Bayer BioLyceum

The prospect of raising capital for early stage companies (pre-seed to Series A) in times of uncertainty always present challenges. Funders continue to invest in companies they have worked with previously, but for the first time entrepreneur or the novice team attracting the right type of capital, the process is longer and more arduous. But...